Use of asparaginase in conjunction with cytosine arabinoside in acute leukemia in children.
D000208:Acute Disease; D001215:Asparaginase / Q000627:therapeutic use*; D001772:Blood Cell Count; D001791:Blood Platelet Disorders / Q000139:chemically induced; D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy*; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008297:Male
D003561:Cytarabine; D001215:Asparaginase